Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2026-05-28 @ 8:45 AM
Study NCT ID:
NCT05689203
Status:
UNKNOWN
Last Update Posted:
2023-01-19
First Post:
2023-01-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19
Sponsor:
Qilu Pharmaceutical Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | COVID-19 | View |
Keywords: